Clinical trial
TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World
NCT00483847 · Biogen, Industry · Completed
Key facts
| NCT number | NCT00483847 |
|---|---|
| Title | TYGRIS - ROW: TYSABRI Global Observational Program in Safety - Rest of World |
| Official title | TYGRIS - ROW: TYSABRI® Global Observational Program in Safety - Rest of World |
| Acronym | TYGRIS - ROW |
| Lead sponsor | Biogen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 4,296 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2014 |
| Completion | Nov 1, 2014 |
| First posted | Jun 7, 2007 |
| Last update posted | Apr 13, 2015 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: